CONCENTRATIONS OF RISK (Details - Revenue and outstanding receivables) - USD ($)	12 Months Ended
	Apr. 30, 2026	Apr. 30, 2025
Concentration Risk [Line Items]
Revenue, net	$ 3,025,538	$ 2,662,105
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customer A [Member]
Concentration Risk [Line Items]
Revenue, net	$ 345,578	$ 1,072,230
Percentage of revenues	11.00%	40.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customer D [Member]
Concentration Risk [Line Items]
Revenue, net	$ 724,484
Percentage of revenues	24.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customer E [Member]
Concentration Risk [Line Items]
Revenue, net	$ 587,010
Percentage of revenues	19.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customers A D And E [Member]
Concentration Risk [Line Items]
Revenue, net	$ 1,657,072
Percentage of revenues	54.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customer B [Member]
Concentration Risk [Line Items]
Revenue, net		$ 972,168
Percentage of revenues		37.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customer C [Member]
Concentration Risk [Line Items]
Revenue, net		$ 374,880
Percentage of revenues		14.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customers A, B And C [Member]
Concentration Risk [Line Items]
Revenue, net		$ 2,419,278
Percentage of revenues		91.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer A [Member]
Concentration Risk [Line Items]
Accounts receivable	$ 188,801	$ 501,512
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer D [Member]
Concentration Risk [Line Items]
Accounts receivable	85,875
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer E [Member]
Concentration Risk [Line Items]
Accounts receivable	146,960
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customers A D And E [Member]
Concentration Risk [Line Items]
Accounts receivable	$ 421,636
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer B [Member]
Concentration Risk [Line Items]
Accounts receivable		494,500
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customer C [Member]
Concentration Risk [Line Items]
Accounts receivable		238,208
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Customers A, B And C [Member]
Concentration Risk [Line Items]
Accounts receivable		$ 1,234,220

VitaNova Life Sciences Corp 10-K